Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
69M
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
70.5M
-
Shares change
-
+4.99M
-
Total reported value, excl. options
-
$300M
-
Value change
-
+$22.6M
-
Number of buys
-
74
-
Number of sells
-
-54
-
Price
-
$4.26
Significant Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) as of Q2 2025
151 filings reported holding OLMA - Olema Pharmaceuticals, Inc. - Common Stock as of Q2 2025.
Olema Pharmaceuticals, Inc. - Common Stock (OLMA) has 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 70.5M shares
.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (6.84M shares), Paradigm Biocapital Advisors LP (6.76M shares), BVF INC/IL (5.3M shares), BlackRock, Inc. (4.61M shares), Woodline Partners LP (3.51M shares), Deep Track Capital, LP (3.44M shares), VANGUARD GROUP INC (3.27M shares), Logos Global Management LP (3.21M shares), JANUS HENDERSON GROUP PLC (3.02M shares), and FRANKLIN RESOURCES INC (3.01M shares).
This table shows the top 120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.